Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Cannabinoid Balance Sleep+ From CBD Products Inc.


NanoZorb Technology - Cannabinoid Balance Sleep+ From Cbd Products Inc.

For those with issues getting to sleep and staying asleep, then fast-acting Cannabinoid Balance Sleep + with melatonin could be a ‘god-send’. Cannabinoid Balance Sleep+ supports your body’s natural sleep cycle, by awakening your endocannabinoid and nervous systems. It is a great way to boost your body’s natural ability to switch off and overcome the symptoms associated with poor quality sleep*. Cannabinoid Balance is made with NanoZorb™ Technology in an FDA registered facility so you can feel safe in the knowledge that you will wake up feeling refreshed, rested, and ready for the day ahead.

Cannabinoid Balance Sleep+ is made using NanoZorb™ Technology, which offers up to 90% absorption into the bloodstream vs 18% with other non-nano products.

Cannabinoid Balance Sleep + is:


  • Crafted from registered organic USA hemp
  • Non-THC / Non-GMO and CO2 Extracted
  • Free from Winterization, Decarboxylation, and pesticides
  • Formulated using proprietary NanoZorb™ Technology

So whether your symptoms be associated with MS, Parkinsons, Opioid Addiction, Epilepsy, High Blood Pressure, Stress, Anxiety, Low Energy, Arthritis, Tendonitis or something else, Cannabinoid Balance Original+ is crafted to support you.*

*The statements and products referred to by Cannabinoid Balance have not been evaluated by the FDA.

CBD Products Inc. is a multi-channel, CBD publishing and retail company established in 2018 that owns and operates cbdproducts.com, cbdworldnews.com and cbdpet.com. In the last year CBD Products Inc. has welcomed more than 25,000 people to their sites and offered information and resources across more than 100,000 page views.

CBD Products Inc. is also the owner of Cannabinoid Balance. A line of consumer products that includes Cannabinoid Balance Original+, Cannabinoid Balance Sleep+, Cannabinoid Balance CBD Gummies+, Cannabinoid Balance Pain Relief Cream and Cannabinoid Balance Pet+. These products are sold via http://www.cbdproducts.com and include proprietary NanoZorb™ Technology designed to make Cannabinoid Balance products more effective and efficient.

It was founded by Anthony Tribunella in 2018. Anthony has worked in all aspects of the industry from growing to production, to publishing and retailing. With more than a decade of experience in CBD and a passion to see the industry become organized and honest, Anthony is rapidly becoming a shining light, thought leader and conscience for the industry he cares so deeply about.

For more information on CBD Products Inc. please visit http://www.cbdproducts.com or email contact@cbdproducts.com.

Share article on social media or email:

GOLO Donates to the Boys & Girls Clubs of Broward County, FL, Supporting “The Rick Case Scholarship Fund”


“We’re delighted to support the Rick Case Scholarship Fund for the Boys and Girls Clubs of Broward County and their excellent mentorship of young people to lead healthy, successful lives,” says Jennifer Brooks, President, GOLO.

GOLO®, a weight loss and wellness solution company, announced a $10,000 contribution to the Boys & Girls Clubs of Broward County, FL, supporting the “Rick Case Scholarship Fund,” continuing its commitment to supporting charitable organizations that promote a diverse and inclusive society that is free from racism, bias, and injustice. The company has committed to donating $100,000 over the next 12 months to charitable organizations throughout the U.S. Additionally, GOLO donated twelve (12) AeroTrainer™ core exercise platforms to each of the Boys & Girls Clubs in Broward County.

“We’re delighted to support the Rick Case Scholarship Fund for the Boys and Girls Clubs of Broward County and their excellent mentorship of young people to lead healthy, successful lives,” says Jennifer Brooks, President, GOLO. “Rick and Rita Case meant so much to South Florida and particularly this organization.”

GOLO is a company dedicated to healthy living with innovative products to support weight-loss, immunity, and a healthy lifestyle.

“At the Boys & Girls Clubs of Broward County, our vision is to provide a world-class club experience that assures that success is within reach for every young person who walks through our doors,” says Chris Gentile, co-CEO. “We are excited to work together with GOLO to ensure our members have the tools they need to live a healthy lifestyle.”

GOLO for Wellness, GOLO for Immunity, GOLO for Weight Loss, GOLO for LIFE®.

About GOLO: GOLO is committed to providing individuals with the knowledge of health and wellness, and the power to take back control of their weight and their lives. The GOLO for Life® plan is an all-natural, plant-based supplement and meal plan, designed to address the root cause of weight gain. The GOLO® products provide a safe solution to weight-loss and wellness while helping individuals transition to a healthier and sustainable lifestyle. GOLO recently launched The AeroTrainer exercise platform, an inflatable core fitness tool that provides quick, easy, home-based workouts. The developers of GOLO, LLC include a team of dedicated doctors, pharmacists, and researchers. GOLO has reached over a million people worldwide who now have a chance at healthy, sustainable, and affordable weight loss. For more information about the GOLO for Life® plan, visit http://www.golo.com or call 800-730-4656 (GOLO). For more information about AeroTrainer, visit http://www.AeroTrainer.com or call 800-799-5838.

Share article on social media or email:

180 Medical Announces 11th Year as One of Oklahoma’s Best Places to Work


News Image

Throughout the year and despite most of us working remotely during this time, we have grown closer as an organization, and we have developed new processes and protocols to ensure the safety of our employees.

180 Medical, one of America’s fastest-growing providers of home-delivered disposable medical supplies, including sterile-use intermittent catheters, ostomy supplies, and incontinence products, is pleased to announce its 11th year being named one of Oklahoma’s Best Places to Work by the Best Companies Group and the Journal Record.

The Best Places Awards are determined through a process of researching Oklahoma-based employers and allowing employees to fill out anonymous surveys regarding their working conditions. 180 Medical is committed to the safety and well-being of all employees and believes that the way employees are treated directly correlates with the level of service they provide the customers of the organization.

This year, Best Companies Groups’ anonymous employee survey included additional questions regarding how well their employer handled COVID-19 workplace communication and safety issues. During the early stages of the COVID-19 outbreak in United States, 180 Medical acted quickly to put their staff’s health first by asking the majority of their employees who are able to perform their jobs remotely to begin working from the safety of their homes. Through digital connections, 180 Medical has made an easy transition for employees to successfully work from home while also fostering positive work relationships.

Director of Human Resources at 180 Medical, Angie Christopher, explained why this honor means something extra special during a global pandemic saying, “In light of the unprecedented year that we all have experienced due to COVID, it is a great feeling to know that our employees still feel that this is a great place to work, and that even in crisis, we strongly care for our employees and their families as much as we do our customers. Throughout the year and despite most of us working remotely during this time, we have grown closer as an organization, and we have developed new processes and protocols to ensure the safety of our employees.  We are proud that, no matter what, we can create an environment that employees continue to enjoy and are proud to work for this company.”

Those interested in joining the 180 Medical team and working for one of the Best Places to Work in Oklahoma are encouraged to visit 180medical.com

About 180 Medical:

180 Medical is one of America’s fastest growing home delivery providers of intermittent catheters, ostomy products, incontinence products, and other related urologic disposable medical supplies. Based in Oklahoma City, the company is dedicated to meeting the supply needs of customers with diagnoses such as urinary incontinence, spinal cord injuries, spina bifida, colon cancer, Crohn’s disease, and many other conditions that require catheterization and ostomy supplies. 180 Medical is a subsidiary of ConvaTec, a leading global medical products and technologies company. For more information, please contact Angie Christopher, Director of Human Resources at 405-702-7700

Share article on social media or email:

Catch brings integrated health insurance enrollment into the full suite of portable benefits


Catch’s Health Insurance Enrollment

“The first of its kind. Catch helps independents put their paychecks, savings, investment, and health insurance all in one place.”

In a year that has been rocked by mass unemployment and rapid adoption of gig and freelance work, staying covered with quality health insurance is more important than ever. For those juggling multiple jobs in the uncertainty of a global pandemic, the confidence of getting an affordable health plan can make all the difference in the world.

Since its launch in 2018, Catch has been building new and innovative ways for independent workers to access meaningful benefits like tax withholding, time off savings, and retirement investment. Now, Catch is also offering an integrated system to provide high quality health insurance options directly to individuals and families who don’t have access to employer-sponsored coverage.

Catch is working with the Centers for Medicare & Medicaid Services (CMS) to offer Enhanced Direct Enrollment (EDE), a system that allows for end-to-end plan shopping, subsidy evaluation, and enrollment in every state on the Federally-facilitated Marketplace.

Put simply, Catch customers who need health insurance this Open Enrollment (Nov 1 – Dec 15) will be able to compare options, see if they’re eligible to cut costs with federal subsidies, and enroll in the right plan all within the Catch app or website.

One of Catch’s customers, Luis Camacho of Phoenix, shares, “What’s great about Catch is that it’s built to help small business owners and freelancers with things like health insurance, tax withholding, and retirement all in one place.”

“The first of its kind. Catch helps independents put their paychecks, savings, investment, and health insurance all in one place,” says Kristen Anderson, co-founder and CEO of Catch.

“Financial and insurance products work together,” says Andrew Ambrosino, Anderson’s co-founder and the company CTO. “You have to build in a way that allows for synthesis of this data. People can’t keep straight how subsidies change year over year, or what tax exemptions there are because of legislation passed during COVID. That’s our job: provide an easy and elegant way to automatically take care of you and your family no matter what.”

Catch is one of fewer than a dozen providers offering the Enhanced Direct Enrollment pathway and has undergone strenuous security and privacy auditing to ensure all customer data is protected.

In an effort to serve independent workers best, says Anderson, “We’re the only provider to offer EDE mobile-first. That means we’ve designed the system primarily for people to use our app or a mobile website. It’s extremely important to make complex processes accessible to those who don’t necessarily have easy access to a laptop or home computer.”

You can sign up for health insurance through Catch’s EDE pathway at health.catch.co.

Share article on social media or email:

ActX Adds COVID-19 Susceptibility Assessment to Genomic Screening


If our inclusion of this susceptibility information can help to better inform individual patients, we will consider the project a success.

ActX’s genetic clinical decision support service, also known as GenoACT, helps physicians provide better care using the patients’ genetic data. Today, ActX announced the addition of a COVID-19 susceptibility section. This information is primarily based on blood type, as that information has been well researched thus far, but will be updated with other genes as evidence for their impact accumulates.

With ActX, once patients are genotyped or sequenced, their genetic data is stored in our secure cloud, and frequently re-analyzed based on advancing medical research. Physicians benefit from real time genetic decision support as they use their Electronic Health Record (EHR) to see patients. Patients can view their ActX results online and are notified when there is an update like the COVID-19 susceptibility data. It is important to note, for those patients whose genetics suggest their susceptibility is lower than most, the genetic impact is only moderate and proper social distancing precautions and mask use should still be observed. This is clearly outlined in the patient’s COVID-19 report.

“The service we have created with ActX helps make genomics actionable in everyday medical practice,” said Dr. Andrew Ury, founder of ActX. “We work hard to keep our service updated with the latest medical research on medications, hereditary risks, and carrier status. We are thrilled to be adding the COVID-19 information to our standard offering. I think that we’ve all seen the wide range of concerns about this virus. If our inclusion of this susceptibility information can help to better inform individual patients, we will consider the project a success. We felt that it was important to address the continuing crisis caused by the COVID-19 pandemic.”

About ActX

ActX is the industry leader in EHR-integrated precision medicine. Our service helps physicians make better decisions about medical treatment, using a patient’s genetic information to guide therapy. The ActX Genomic Service offers proven, tightly integrated, real-time genomic decision support for medication orders and actionable genomic risks, a built in patient Genomic Profile, and the ability to fully customize content.

As medications are ordered, and before the prescription is finalized, medications are checked against the patient’s genetics for efficacy, adverse reactions, and dosing. Extensive evidence based and actionable content is provided as default, customizable content, covering hundreds of genes. You can easily suppress any content or interactions, or add or modify content. The ActX Genomic Service is live at numerous U.S. health systems. For more information, visit http://www.actx.com, email info@actx.com or call 888-998-2289.

Share article on social media or email:

Tergus Pharma and Phenom Pharmaceuticals Collaborate to Develop Novel Delivery System for SARS-CoV-2 Anti-Binding Agent


Tergus Pharma and Phenom Pharmaceuticals announced today that they have entered into an agreement for Tergus to develop a unique delivery solution to help prevent infection by the SARS-CoV-2 virus.

Phenom Pharmaceuticals will use a proprietary delivery pathway and unique molecule to prevent viral infection. The SARS-CoV-2 virus causes COVID-19, the source of a current global pandemic that has severely impacted the health of millions of people.

“Tergus is thrilled to work together with Phenom on such an impactful project,” said Dr. Vijendra Nalamothu, Ph.D., Chairman and CEO of Tergus Pharma. “This has the potential to have a huge impact on global health and wellness in the future.”

Dr. Michelle L. Rivera, MD, founder and CEO of Phenom Pharmaceuticals, said, “Tergus’ reputation as a global leader in topical pharmaceutical R&D and manufacturing is a perfect fit for our ground-breaking concept to help prevent the spread of COVID-19.”

Once Tergus has completed the initial phases of formulation development, Phenom will begin securing additional funding for further testing and development.

About Tergus Pharma

Tergus Pharma is an end-to-end service provider for topical pharmaceutical research, drug development, testing, and manufacturing, and has been an industry leader for several years with a state-of-the-art facility in Durham, North Carolina. The company has a long and stellar reputation for delivering quality results to clients, from formulation through clinical supplies manufacturing, earning the company the tagline, “Think Topicals, Think Tergus.” Tergus will be expanding its capabilities for topical pharmaceutical R&D and manufacturing as it moves to a brand-new, 100,000 sq. ft. facility in Q1, 2021. Tergus scientifically helps its clients achieve the right balance between speed and quality. For more information, please visit https://www.TergusPharma.com/

About Phenom Pharmaceuticals

Phenom Pharmaceuticals is an innovative, privately held pharmaceutical company focused on delivering scientifically elegant and revolutionary solutions to worldwide health issues. Our focus is creating highly effective, safe, and timely modern drugs that will significantly protect and improve human health. Phenom’s board has over 50 years of combined experience in clinical medicine and research at leading institutions, including Harvard Medical School, Merck, Lever Brothers, Duke University Medical Center, Columbia University, and the University of North Carolina at Chapel Hill.

Share article on social media or email:

Center for Vein Restoration (CVR) Venous and Lymphatic Medicine Fellowship Largest in Country


logo

Fellows in our program represent the future of treating venous and lymphatic disorders nationwide.

As of July 2020, Center for Vein Restoration’s Venous and Lymphatic Medicine Graduate Medical Education Training Program, became the largest American Board of Venous and Lymphatic Medicine (ABVLM) approved training site in the United States. Since the Fall of 2017, the program has graduated four VLM fellows and currently has four fellows in training. The program is currently accepting applications for four fellowship positions for the 2021-2022 graduating class. The prestigious 12-month program allows trainees to develop expertise in all aspects of non-invasive duplex scanning of the venous and arterial systems, the diagnosis and management of superficial and deep venous disorders, and all methods for treating chronic venous insufficiency (CVI), as well as an opportunity to consult and treat patients suffering from venous disorders like Pelvic Congestion Syndrome and May Thurner’s Syndrome. Fellows have a choice of training in New Jersey, Maryland, or Virginia.

“Fellows in our program represent the future of treating venous and lymphatic disorders nationwide,” said CVR’s CEO and Founder Dr. Sanjiv Lakhanpal, “We are committed to the education of physicians specifically trained in venous disorders so that we can continue to deliver on our mission – to improve lives in the communities we serve by providing state-of-the-art-vascular care.”

The program has grown substantially in both size and geographic reach since 2017 under the leadership of Dr. Peter Pappas, Vascular Surgeon and Regional Medical Director for CVR in Northern New Jersey. As a nationally recognized clinical researcher and educator with over 25 years of academic experience in Vascular Surgery, he is uniquely qualified to serve as the Director of CVR’s Venous and Lymphatic Medicine Program and as a member of its distinguished faculty.

“What sets our Fellowship Program apart is its association with the clinical leaders in vein care – Center for Vein Restoration – which provides trainees unfettered access to internationally recognized faculty, cutting-edge treatment technologies, and patients in every walk of life,” says Dr. Pappas.

The curriculum for the program includes a quarterly rotation through the various aspects of disease diagnosis and treatment; a clinical literature journal club; a didactic lecture series; and a Navix or Pegasus Review Course. A month-long Observership at Innova Health in Virginia, under the supervision of Dr. Tony Comerota is also included.

To learn more and apply to CVR’s Venous & Lymphatic Medicine Fellowship Program:

ABOUT CENTER FOR VEIN RESTORATION

Center for Vein Restoration (CVR) is the largest physician-led practice treating venous disease in the country. Having performed its first procedure in 2007 under President and CEO Dr. Sanjiv Lakhanpal, Center for Vein Restoration has since become nationally recognized as the clinical leader in treating chronic venous insufficiency. With 90 centers and growing, CVR has over 450 employees and conducts over 200,000 patient interactions annually. To learn more about CVR and its mission, visit http://www.centerforvein.com or by phone at 1-800-FIX-LEGS.

Share article on social media or email:

Former Senior Director of Clinical Laboratory Quality, Julie Ballard, Joins NDA Partners as Expert Consultant


News Image

Ms. Ballard’s expertise in building new clinical laboratories and quality systems, in addition to her knowledge of CAP and CLIA accreditation and state regulations, makes her a valuable resource to our clients developing laboratory-developed tests and establishing CLIA-certified laboratories.

NDA Partners Chairman Carl Peck, MD, announced today that Julie Ballard, a Clinical Laboratory Scientist, has joined the firm as an Expert Consultant. Ms. Ballard’s expertise includes building new clinical laboratories and quality systems, regulatory compliance, laboratory operations and management, CAP and CLIA accreditation, and state regulations through the Laboratory Field Services (LFS) program in California and the Clinical Laboratory Evaluation Program (CLEP) in New York.

In addition, Ms. Ballard has experience launching novel high-complexity laboratory-developed tests including liquid biopsy-based next-generation sequencing and tissue-based gene expression profiling oncology tests, and phenotypic/genotypic HIV drug-resistance testing. Throughout her 25-year career, she has provided leadership and operational expertise to biotechnology start-up companies, including her recent position as Senior Director of Clinical Laboratory Quality at Seer, Inc. She also served in Clinical Laboratory and Quality Director positions at GRAIL, Guardant Health, TOMA Biosciences, and Genomic Health.

“Ms. Ballard’s expertise in building new clinical laboratories and quality systems, in addition to her knowledge of CAP and CLIA accreditation and state regulations, makes her a valuable resource to our clients developing laboratory-developed tests and establishing CLIA-certified laboratories,” said Dr. David Feigal, Manager of NDA Partners’ medical device practice.

Ms. Ballard earned her bachelor’s degree in clinical science from San Francisco State University. She is a California-licensed Clinical Laboratory Scientist and is certified by the American Society of Clinical Pathologists (ASCP) as a Medical Technologist.

About NDA Partners

NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Contact

Earle Martin, Chief Executive Officer

Office: 540-738-2550

MartinEarle@ndapartners.com

Share article on social media or email:

World Class Eating Disorders Professionals Offer Perspective at International Virtual Training Event, November 13-14, 2020


“As we continue to engage and expand globally, our iaedp™ International Chapter has set the stage for its second Professional Training in Spanish with an added bonus of being conducted virtually,” said Blanche Williams, iaedp™ Director of International Development.

Coming soon from iaedp™’s International Chapter is a two-day virtual training for eating disorders treatment professionals slated for November 13 (8:00 a.m.- 6:00 p.m. EST) and November 14 (8:30 a.m. – 2:30 p.m. EST) delivered in Spanish only by a renowned collective of experts in the field. The International Association of Eating Disorders Professionals (iaedp™) is a premiere provider of educational programs and training standards for eating disorder treatment specialists and other healthcare professionals.

The training is hosted by iaedp™’s International Chapter Chair of Mexico Dra. JulietaVélez-Belmonte, MS, PsyD, CEDS, NCC-OPCA with sponsorship from Neandi Psychological Specialities and Feelink digital Community and with support from the Ibero-American Commission on Human Rights. The theme for the training is “The Body, Land of the Image.”

Early registration is already underway for the International Chapter Professional Training and lasts until Monday, November 9, 2020. The cost for the two-day training session is $130 during early registration and $145 after that. A “Friends” group rate for two colleagues registering together will be $100 each.

“As we continue to engage and expand globally, our iaedp™ International Chapter has set the stage for its second Professional Training in Spanish with an added bonus of being conducted virtually which provides more access and safety to busy professionals,” said Blanche Williams, iaedp™ Director of International Development.

The following are training program presenters:

Dra. Julieta Velez, MS, PsyD, CEDS, NCC-OPCA is a psychologist from the Universidad Nacional Autonoma in Mexico, masters in Clinical Psychology and Psychotherapy, a specialist in brief psychotherapy from the Universidad Anahuac Mexico. She also is a doctor in Family Sciences by the Instituto de Enlaces Educativo with research in families. She is the Dean of the School of Psychology of the Universidad Anáhuac Puebla and a renowned international lecturer.

Dra. Juanita Gempler is a clinical psychologist at Universidad Javeriana de Bogota with a degree in Behavioral Cognitive Therapy from the University of London. She is a Fellow of the Academy for Eating Disorders and Founder and Scientific Director of Equilibrio, a program for the evaluation and management of eating disorders, mood and anxiety in Bogota.

Dra. Aridia Vasquez, MD, MS, RD is a medical doctor, registered dietitian and specialist in eating disorders and intuitive eating. She currently services as the medical director of Renovates by CPE, the first bilingual multidisciplinary treatment center for eating disorders in the Dominican Republic and serves as the iaedp™ International Chapter Co-Chair of the Dominican Republic.

Dra. Eva Trujillo, MD, FAED is Director and Co-Founder of Comenzar de Nuevo AC, former president of the Academy for Eating Disorders and clinical professor at the TEC Salud School of Medicine. She is also Vice President and Co-Founder of the Mexican College of Professionals in Eating Disorders.

Dra. Zuleika Morillo, MD is a child and adolescent psychiatrist from the Hospital Clinico de San Carlos, Madrid and a child and adolescent medical psychotherapist. She is a specialist in adolescent integral health from the Technological University of Sano Domingo and a specialist in Abuse, Neglect and Wellness from the Universidad de Salamanca, Spain while also serving as the iaedp™ International Chapter Co-Chair of the Dominican Republic.

Dra. Rosanna Mauro, MS, RD, CEDRD-S, NBC-HWC is a registered dietitian, holds a Master in Group Psychology and is a Certified Integrative Health Coach, through the University of Arizona and the Andrew Weil Center for Integrative Medicine. She is the International Chapter President along with being an iaedp ™ Certified Eating Disorders Specialist (CEDRD-S) and Approved Supervisor.

Dr. Emmett Bishop, Jr., MD, FAED, F. iaedp, CEDS is a psychiatrist with more than 40 years of experience in the research and clinical practice of eating disorders, and the Co-Founder and former Medical Director at Eating Recovery Center in Denver, Colorado. He currently serves on the iaedp™ Board of Directors, past president and treasurer.

Dr. Antonio Tena, PsyD has a degree in Psychology from the Universidad Iberoamericana, Master in Clinical Psychology from the National Autonomous University of Mexico. He also has a specialty in Dynamic Psychiatry in Mexican Psychoanalytic Association and is a Doctor of Psychology from the Universidad Iberoamericana.

Dr. Rodrigo César León Hernandez, PsyD, has a doctorate in psychology from the National Autonomous University of Mexico, CONACYT professor and member of the National System of Researchers Level I. He has a master’s degree in the Taking Control of Your Health program from Stanford University, as well as a master’s degree in the chronic disease management program from Flinders University Australia. He is a member of iaedp™ and of the risk factors research group and director of Centro Alianza para trastornos de alimentación y salud (CAPTAS).

REGISTRATION: https://iaedp.site-ym.com/event/ElCuerpoTerritorioDeLaImagen

Learn more about our International Chapter:

https://membershare.iaedp.com/international-chapter/

https://membershare.iaedp.com/international-chapter/en-espanol/

Share article on social media or email:

U.S. Dermatology Partners Waco Office Receives 2020 H.O.T. (Heart of Texas) Reader’s Choice Award in 2 Categories


Waco Trib H.O.T. Best Dermatologist

Waco Trib H.O.T. Best Dermatologist

“It’s an honor to serve Waco and surrounding areas. We look forward to continuing to provide superior and compassionate care to the community that Dr. Walker and I are proud to call home for many years to come.” Said Young McMahan, MD

U.S. Dermatology Partners Waco office is being recognized by their readers as Best Dermatologist and Best in Cosmetic Surgery in Waco Trib’s annual Readers’ Choice award.

This prestigious readers’ choice poll is conducted annually to recognize and reward the people, places, and things that make the Heart of Texas special. Readers cast their votes for their favorites during the official two-week voting period from August 9-23rd.

“Thank you to our patients for voting us H.O.T. Best Dermatologist and Best Cosmetic Dermatologist for 2020. It’s an honor to serve Waco and the surrounding areas. We look forward to continuing to provide superior and compassionate dermatology care to the community that Dr. Walker and I are proud to call our home for many years to come,” said Young McMahan, MD

Dr. McMahan and Dr. Walker both serve as volunteer faculty staff at the Family Health Center to help provide dermatology education to the residents. Dr. McMahan continues to serve on the board of the McLennan County Medical Society and is in her second term as a delegate for the Texas Medical Association. Dr. McMahan and Dr. Walker are happy to welcome Shae Young. PA-C to their patient care team.

The office has been serving Waco and the surrounding community since 2015. The center includes Board Certified Dermatologist, Dr. Young McMahan, Dr. Greg Walker, Dr. Nick Snavely, and Shea K. Young, PA-C. Dr. McMahan joined the Waco practice of U.S. Dermatology Partners following her dermatology residency at the University of Texas Medical Branch in Galveston where she served as chief resident. Dr. Walker joined the practice after completing his dermatology residency at Baylor Scott and White in Temple, Texas. He spent the final year of his training as chief resident. Dr. Snavely completed a dermatology residency at the University of Virginia in Charlottesville, Virginia, and then completed an advanced dermatologic surgery fellowship at Oregon Health & Science University in Portland, Oregon.

About U.S. Dermatology Partners Waco

At U.S. Dermatology Partners Waco, your skin health is important to us. From protecting your skin from harm or restoring it to health, we have the expertise and technology to treat a vast array of skin conditions. Our specialized skin cancer procedures have produced substantial cure results and our expert treatment of acne, dermatitis, psoriasis, and other common skin conditions continue to expand. With the development of additional physician and nursing resources, treatment options, and advanced clinical trials, we are ready to help. At our Waco dermatology clinic, our goal is to provide you with the most convenient, restorative experience possible every time you visit – from initial consultation to treatment to follow-up. We hope you will make us your skin care partner for life.

About U.S. Dermatology Partners

As one of the largest physician-owned dermatology practices in the country, U.S. Dermatology Partners’ patients not only have access to general medical, surgical, and cosmetic skin treatments through its coordinated care network but also benefit from the practice’s strong dermatology subspecialty thought leaders and medical advisory board. To be the best partners to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com.

Share article on social media or email: